CARM - Carisma Therapeutics Inc.
IEX Last Trade
0.4997
0.054 10.847%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:24:22 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$0.45
0.05
12.17%
Summary score
27%
Profitability
29%
Dept financing
17%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
20.59%
Return on assets
-9.7%
Return on sales
-360.41%
Return on invested capital
500.21%
Total debt ratio
58.98%
Debt ratio change over timeo
-2.46%
Current Ratio
8.36%
Quick Ratio
8.36%
Cash Position Ratio
7.48%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-82.3%
Return on assets
-22.05%
Return on sales
-567.63%
Return on invested capital
1876.33%
Total debt ratio
65.53%
Debt ratio change over timeo
-2.03%
Current Ratio
6.01%
Quick Ratio
6.01%
Cash Position Ratio
5.74%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-174.19%
Return on assets
-26.44%
Return on sales
-574.33%
Return on invested capital
6347.16%
Total debt ratio
85.24%
Debt ratio change over time
-0.72%
Current Ratio
4.64%
Quick Ratio
4.64%
Cash Position Ratio
4.3%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-186.7%
Return on assets
-88.92%
Return on sales
260.1%
Return on invested capital
-312.22%
Total debt ratio
-246.06%
Debt ratio change over time
-2.46%
Current Ratio
-53.27%
Quick Ratio
-53.27%
Cash Position Ratio
-42.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CARM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 20.59% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.7% | 2.76% | 3.15% | 5.62% |
| Return on sales | -360.41% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 500.21% | 2.36% | 5.39% | 19.77% |
| Profitability | 40% | 40% | 59% | 56% |
| Total debt ratio | 58.98% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -2.46% | 308.97% | -6.99% | 1.18% |
| Dept financing | 16% | 50% | 25% | 7% |
| Current Ratio | 6.01% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.01% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.74% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 14% | 31% |
| Short-term ratios | CARM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -82.3% | 13.77% | 13.25% | 3.8% |
| Return on assets | -22.05% | 2.43% | 1.89% | 3.09% |
| Return on sales | -567.63% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 1876.33% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 57% |
| Total debt ratio | 65.53% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -2.03% | 46.38% | -72.08% | 1.51% |
| Dept financing | 18% | 50% | 25% | 7% |
| Current Ratio | 6.01% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.01% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.74% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 22% | 55% |